We are live on ! Find out more
SurgoCap Partners

SurgoCap Partners Portfolio holdings

AUM $3.04B Turnover 50%
1-Year Est. Return 53.06%
 

SurgoCap Partners is an investment firm focused on how technology innovation reshapes global markets over the long term. Mala Gaonkar, a former portfolio manager at Lone Pine Capital, founded it in 2022 and leads its investing as managing principal and chief investment officer. The firm runs private funds, in the US and overseas, for sophisticated and institutional investors.

This Fund
S&P 500
This Quarter Est. Return
+0.06%
1 Year Est. Return
+53.06%
3 Year Est. Return
+285.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.04B
AUM Growth
-$51.1M
Cap. Flow
+$121M
Cap. Flow %
3.96%
Top 10 Hldgs %
96.3%
Holding
16
New
3
Increased
7
Reduced
1
Closed
5
Avg Time Held
1.1 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$265M
2
MCK icon
McKesson
MCK
+$173M
3
HLT icon
Hilton
HLT
+$167M
4
MELI icon
Mercado Libre
MELI
+$125M
5
TSM icon
TSMC
TSM
+$75M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$341M
2
GLW icon
Corning
GLW
+$204M
3
AGX icon
Argan
AGX
+$120M
4
ISRG icon
Intuitive Surgical
ISRG
+$102M
5
MDLN icon
Medline
MDLN
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 34.23%
2 Healthcare 23.71%
3 Financials 22.29%
4 Industrials 10.5%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TSM icon
1
TSMC
TSM
$1.91T
$495M 16.27%
1,085,185
+177,121
+20% +$75M
2025 Q3
4 quarters
MCK icon
2
McKesson
MCK
$125B
$493M 16.21%
577,584
+200,714
+53% +$173M
2023 Q4
11 quarters
LPLA icon
3
LPL Financial
LPLA
$21.5B
$349M 11.48%
1,141,781
+78,563
+7% +$26.7M
2023 Q4
11 quarters
CRS icon
4
Carpenter Technology
CRS
$13.6B
$320M 10.5%
821,880
+135,407
+20% +$68.8M
2024 Q3
8 quarters
MSFT icon
5
Microsoft
MSFT
$3.87T
$294M 9.67%
+573,423
New +$265M
2026 Q3
0 quarters
INTC icon
6
Intel
INTC
$310B
$252M 8.29%
2,098,348
+250,033
+14% +$25.5M
2026 Q2
1 quarter
MDLN icon
7
Medline
MDLN
$34.1B
$228M 7.5%
6,575,970
-911,537
-12% -$33.3M
2026 Q1
2 quarters
V icon
8
Visa
V
$768B
$216M 7.11%
601,988
+37,781
+7% +$13.8M
2026 Q1
2 quarters
HLT icon
9
Hilton
HLT
$81.9B
$166M 5.44%
+520,612
New +$167M
2026 Q3
0 quarters
MELI icon
10
Mercado Libre
MELI
$72.3B
$116M 3.83%
+67,356
New +$125M
2026 Q3
0 quarters
NU icon
11
Nu Holdings
NU
$59.1B
$113M 3.7%
8,889,734
+889,006
+11% +$12.6M
2023 Q4
11 quarters
AGX icon
12
Argan
AGX
$4.35B
– –
-149,983
Closed -$120M –
GLW icon
13
Corning
GLW
$97.7B
– –
-797,181
Closed -$204M –
GOOG icon
14
Alphabet (Google) Class C
GOOG
$3.58T
– –
-966,080
Closed -$341M –
ISRG icon
15
Intuitive Surgical
ISRG
$147B
– –
-256,963
Closed -$102M –
DPC
16
DPC Holdings
DPC
$4.94B
– –
-638,725
Closed -$31.3M –

Similar funds

SurgoCap Partners's Q3 2026 Portfolio in Review

As of Q3 2026, SurgoCap Partners held 16 positions worth $3.04B, down 1.7% from $3.09B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

SurgoCap Partners deployed $121M of net new capital in Q3 2026, opening 3 new positions and adding to 7 existing holdings. Its largest new stake was Microsoft: 573,423 shares worth $294M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medline, an estimated $33.3M trimmed.

  • SurgoCap Partners's largest Q3 2026 buy was Microsoft: 573,423 shares worth $294M.
  • SurgoCap Partners added most to McKesson in Q3 2026, an estimated $173M increase.
  • SurgoCap Partners's biggest Q3 2026 reduction was Medline, cutting an estimated $33.3M.
  • SurgoCap Partners fully exited Alphabet (Google) Class C in Q3 2026, selling an estimated $341M.
  • SurgoCap Partners's ten largest holdings make up 96% of its $3.04B portfolio in Q3 2026.
  • SurgoCap Partners opened 3 new positions and closed 5 in Q3 2026.
  • SurgoCap Partners's portfolio value fell 1.7% quarter-over-quarter to $3.04B.

Based on SurgoCap Partners's 13F filing for Q3 2026, filed 16 Nov 2026.